Parkin disease: A clinicopathologic entity?

JAMA Neurology

Volumn 70, Issue 5, 2013, Pages 571-579

  Doherty, Karen M ^a,b   Silveira Moriyama, Laura ^a,b,h   Parkkinen, Laura ^d   Healy, Daniel G ^e   Farrell, Michael ^e   Mencacci, Niccolo E ^b,i   Ahmed, Zeshan ^b   Brett, Francesca M ^e   Hardy, John ^a,b   Quinn, Niall ^b   Counihan, Timothy J ^g   Lynch, Timothy ^f   Fox, Zoe V ^c   Revesz, Tamas ^a,b   Lees, Andrew J ^a,b   Holton, Janice L ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e BEAUMONT HOSPITAL   (Ireland)

^f MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^g NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^h UNIVERSITY OF CAMPINAS   (Brazil)

ⁱ ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA PLUS ENTACAPONE PLUS LEVODOPA; CHOLINERGIC RECEPTOR BLOCKING AGENT; PARKIN; SELEGILINE;

ADULT; ARTICLE; BRADYKINESIA; BRAIN REGION; CATALEPSY; CELL LOSS; CLINICAL ARTICLE; CLINICAL FEATURE; CONFUSION; DISEASE SEVERITY; DISORIENTATION; DYSTONIA; EXON; FEMALE; FOCAL DYSTONIA; GENE MUTATION; GLIOSIS; HAND TREMOR; HETEROZYGOSITY; HUMAN; IMMUNOREACTIVITY; LEG TREMOR; LOCUS CERULEUS; MALE; MISSENSE MUTATION; MOTONEURON NUCLEUS; NERVE CELL; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; RAPHE NUCLEUS; STOP CODON; SUBSTANTIA NIGRA PARS COMPACTA; TREMOR; VISUAL HALLUCINATION;

EID: 84877727171     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.172     Document Type: Article

References (44)

1. Ishikawa A, Tsuji S. Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism. Neurology. 1996;47(1):160-166. (Pubitemid 26243878)
2. Matsumine H, Saito M, Shimoda-Matsubayashi S, et al. Localization of a gene for an autosomal recessive form of juvenile parkinsonism to chromosome 6q25.2-27. Am J Hum Genet. 1997;60(3):588-596. (Pubitemid 27097607)
3. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998;392(6676):605-608. (Pubitemid 28207717)
4. Khan NL, Brooks DJ, Pavese N, et al. Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study. Brain. 2002;125(pt 10):2248-2256.
5. Khan NL, Graham E, Critchley P, et al. Parkin disease: a phenotypic study of a large case series. Brain. 2003;126(pt 6):1279-1292. (Pubitemid 36644375)
6. Khan NL, Horta W, Eunson L, et al. Parkin disease in a Brazilian kindred: manifesting heterozygotes and clinical follow-up over 10 years. Mov Disord. 2005;20(4):479-484. (Pubitemid 40779024)
7. Khan NL, Katzenschlager R, Watt H, et al. Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease. Neurology. 2004;62(7):1224-1226. (Pubitemid 38456528)
8. Lohmann E, Periquet M, Bonifati V, et al French Parkinson's Disease Genetics Study Group; European Consortium on Genetic Susceptibility in Parkinson's Disease. How much phenotypic variation can be attributed to parkin genotype? Ann Neurol. 2003;54(2):176-185.
9. Kim HJ, Kim HJ, Lee JY, et al. Phenotype analysis in patients with early onset Parkinson's disease with and without parkin mutations. J Neurol. 2011;258(12):2260-2267.
10. Lücking CB, Dürr A, Bonifati V, et al French Parkinson's Disease Genetics Study Group; European Consortium on Genetic Susceptibility in Parkinson's Disease. Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med. 2000;342(21):1560-1567. (Pubitemid 30340501)
11. Klein C, Pramstaller PP, Kis B, et al. Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype. Ann Neurol. 2000;48(1):65-71. (Pubitemid 30432432)
12. Nichols WC, Pankratz N, Uniacke SK, et al. Linkage stratification and mutation analysis at the Parkin locus identifies mutation positive Parkinson's disease families. J Med Genet. 2002;39(7):489-492. (Pubitemid 34787742)
13. Hristova VA, Beasley SA, Rylett RJ, Shaw GS. Identification of a novel Zn2+-binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin. J Biol Chem. 2009;284(22):14978-14986.
14. Yao Z, Wood NW. Cell death pathways in Parkinson's disease: role of mitochondria. Antioxid Redox Signal. 2009;11(9):2135-2149.
15. Deas E, Wood NW, Plun-Favreau H. Mitophagy and Parkinson's disease: the PINK1-parkin link. Biochim Biophys Acta. 2011;1813(4):623-633.
16. Yamamura Y, Kuzuhara S, Kondo K, et al. Clinical, pathologic and genetic studies on autosomal recessive early-onset parkinsonism with diurnal fluctuation. Parkinsonism Relat Disord. 1998;4(2):65-72. (Pubitemid 28525352)
17. Mori H, Kondo T, Yokochi M, et al. Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology. 1998;51(3):890-892. (Pubitemid 28449284)
18. Hayashi S, Wakabayashi K, Ishikawa A, et al. An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene. Mov Disord. 2000;15(5):884-888.
19. van de Warrenburg BPC, Lammens M, Lücking CB, et al. Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations. Neurology. 2001;56(4):555-557. (Pubitemid 32172889)
20. Farrer M, Chan P, Chen R, et al. Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol. 2001;50(3):293-300. (Pubitemid 32848731)
21. Mori H, Hattori N, Mizuno Y. Genotype-phenotype correlation: familial Parkinson disease. Neuropathology. 2003;23(1):90-94. (Pubitemid 36406793)
22. Gouider-Khouja N, Larnaout A, Amouri R, et al. Autosomal recessive parkinsonism linked to parkin gene in a Tunisian family: clinical, genetic and pathological study. Parkinsonism Relat Disord. 2003;9(5):247-251. (Pubitemid 36627689)
23. Sasaki S, Shirata A, Yamane K, Iwata M. Parkin-positive autosomal recessive juvenile Parkinsonism with alpha-synuclein-positive inclusions. Neurology. 2004;63(4):678-682. (Pubitemid 39100825)
24. Pramstaller PP, Schlossmacher MG, Jacques TS, et al. Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers. Ann Neurol. 2005;58(3):411-422. (Pubitemid 41266627)
25. Orimo S, Amino T, Yokochi M, et al. Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2. Mov Disord. 2005;20(10):1350-1353. (Pubitemid 41645912)
26. Torres L CM, Mata I, Mazzetti PE, et al. A novel PARK2 mutation in a Peruvian family: clinical and pathological characteristics. Mov Disord. 2011;26(suppl 2):S311-S312.
27. Miyakawa S, Ogino M, Funabe S, et al. Lewy body pathology in a patient with a homozygous parkin deletion. Mov Disord. doi:10.1002/mds.25346.
28. Ozawa T, Paviour D, Quinn NP, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain. 2004;127(pt 12):2657-2671. (Pubitemid 39627375)
29. McKeith IG, Dickson DW, Lowe J, et al Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65(12):1863-1872. (Pubitemid 43970103)
30. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003;24(2):197-211. (Pubitemid 36007810)
31. Halliday G. Substantia nigra and locus coeruleus. In: Paxinos G, Juergen KM, eds. The Human Nervous System. 2nd ed. London, England: Elsevier Academic Press; 2004:449-463.
32. Ma SY, Collan Y, Röyttä M, Rinne JO, Rinne UK. Cell counts in the substantia nigra: a comparison of single section counts and disector counts in patients with Parkinson's disease and in controls. Neuropathol Appl Neurobiol. 1995;21(1):10-17.
33. Ahlskog JE. Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's disease. Parkinsonism Relat Disord. 2009;15(10):721-727.
34. Paisán-Ruiz C, Li A, Schneider SA, et al. Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiol Aging. 2012;33(4):814-823.
35. Samaranch L, Lorenzo-Betancor O, Arbelo JM, et al. PINK1-linked parkinsonism is associated with Lewy body pathology. Brain. 2010;133(pt 4):1128-1142.
36. Cookson MR, Hardy J, Lewis PA. Genetic neuropathology of Parkinson's disease. Int J Clin Exp Pathol. 2008;1(3):217-231.
37. Poulopoulos M, Levy OA, Alcalay RN. The neuropathology of genetic Parkinson's disease. Mov Disord. 2012;27(7):831-842.
38. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988;51(6):745-752.
39. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain. 1991;114(pt 5):2283-2301.
40. Parkkinen L, Soininen H, Laakso M, Alafuzoff I. Alpha-synuclein pathology is highly dependent on the case selection. Neuropathol Appl Neurobiol. 2001;27(4):314-325. (Pubitemid 32758618)
41. Markesbery WR, Jicha GA, Liu H, Schmitt FA. Lewy body pathology in normal elderly subjects. J Neuropathol Exp Neurol. 2009;68(7):816-822.
42. Sriram SR, Li X, Ko HS, et al. Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin. Hum Mol Genet. 2005;14(17):2571-2586. (Pubitemid 41236069)
43. Cookson MR, Lockhart PJ, McLendon C, O'Farrell C, Schlossmacher M, Farrer MJ. RING finger 1mutations in Parkin produce altered localization of the protein. Hum Mol Genet. 2003;12(22):2957-2965. (Pubitemid 37442024)
44. Klein C, Lohmann-Hedrich K, Rogaeva E, Schlossmacher MG, Lang AE. Deciphering the role of heterozygous mutations in genes associated with parkinsonism. Lancet Neurol. 2007;6(7):652-662. (Pubitemid 46921058)